19 November 2017
News and Views
Links and Services
This week's New England Journal of Medicine examines the use of eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
Eltrombopag is an oral thrombopoietin-receptor agonist.
Dr Nezam Afdhal a
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors